{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T17:41:33Z","timestamp":1696959693235},"reference-count":52,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2003,11,1]],"date-time":"2003-11-01T00:00:00Z","timestamp":1067644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T00:00:00Z","timestamp":1675987200000},"content-version":"vor","delay-in-days":7041,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Nutrition"],"published-print":{"date-parts":[[2003,11]]},"DOI":"10.1093\/jn\/133.11.3767s","type":"journal-article","created":{"date-parts":[[2018,1,22]],"date-time":"2018-01-22T06:31:40Z","timestamp":1516602700000},"page":"3767S-3772S","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Cancer Genetics in Primary Care"],"prefix":"10.1016","volume":"133","author":[{"suffix":"Jr.","given":"Kent D.","family":"McKelvey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James P.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1093\/jn\/133.11.3767S_bib1","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0248-8663(97)89326-5","article-title":"UV-induced immunosuppression and skin cancers","volume":"19","author":"Meunier","year":"1998","journal-title":"Rev. Med. Interne"},{"key":"10.1093\/jn\/133.11.3767S_bib2","first-page":"5950","article-title":"Human papillomavirus and the risk of anogenital cancer","volume":"164","author":"Melbye","year":"2002","journal-title":"Ugeskr. Laeger"},{"key":"10.1093\/jn\/133.11.3767S_bib3","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2188\/jea.13.99","article-title":"The relationship of thyroid cancer with radiation exposure from nuclear weapon testing in the Marshall Islands","volume":"13","author":"Takahashi","year":"2003","journal-title":"J. Epidemiol"},{"key":"10.1093\/jn\/133.11.3767S_bib4","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/ijc.11043","article-title":"Attributable and absolute risk of lung cancer death by smoking status: Findings from the Japan collaborative cohort study","volume":"105","author":"Ando","year":"2003","journal-title":"Int. J. Cancer"},{"key":"10.1093\/jn\/133.11.3767S_bib5","unstructured":"Nussbaum, R. L., McInnes, R. R., Willard, H. F. & Thompson, M. W. (2001) Thompson & Thompson Genetics in Medicine, 6th ed. Saunders,Philadelphia, PA."},{"key":"10.1093\/jn\/133.11.3767S_bib6","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1093\/jnci\/90.14.1039","article-title":"The concise handbook of family cancer syndromes. Mayo Familial Cancer Program","volume":"90","author":"Lindor","year":"1998","journal-title":"J. Natl. Cancer Inst"},{"issue":"suppl","key":"10.1093\/jn\/133.11.3767S_bib7","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1002\/(SICI)1097-0142(19991201)86:11+<2525::AID-CNCR9>3.0.CO;2-7","article-title":"Integration of family history and medical management of patients with hereditary cancers","volume":"86","author":"Tinley","year":"1999","journal-title":"Cancer"},{"key":"10.1093\/jn\/133.11.3767S_bib8","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3322\/canjclin.53.1.5","article-title":"Cancer statistics, 2003","volume":"53","author":"Jemal","year":"2003","journal-title":"CA Cancer J. Clin"},{"key":"10.1093\/jn\/133.11.3767S_bib9","first-page":"114","article-title":"Hereditary breast cancer. Identifying and managing BRCA1 and BRCA2 carriers","volume":"45","author":"Heisey","year":"1999","journal-title":"Can. Fam. Physician"},{"key":"10.1093\/jn\/133.11.3767S_bib10","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1086\/301749","article-title":"Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium","volume":"62","author":"Ford","year":"1998","journal-title":"Am. J. Hum. Genet"},{"key":"10.1093\/jn\/133.11.3767S_bib11","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1200\/JCO.2002.20.5.1260","article-title":"Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers","volume":"20","author":"Scheuer","year":"2002","journal-title":"J. Clin. Oncol"},{"key":"10.1093\/jn\/133.11.3767S_bib12","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1056\/NEJM200010123431506","article-title":"Primary care for survivors of breast cancer","volume":"343","author":"Burstein","year":"2000","journal-title":"N. Engl. J. Med"},{"key":"10.1093\/jn\/133.11.3767S_bib13","first-page":"A21","article-title":"Frequency of breast cancer attributable to BRCA1 and BRCA2 in a population-based series of Caucasian and African-American women","volume":"65","author":"Mu","year":"1999","journal-title":"Am. J. Hum. Genet"},{"key":"10.1093\/jn\/133.11.3767S_bib14","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1056\/NEJM199705153362001","article-title":"The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews","volume":"336","author":"Struewing","year":"1997","journal-title":"N. Engl. J. Med"},{"key":"10.1093\/jn\/133.11.3767S_bib15","first-page":"496","article-title":"Prevalence and contribution of BRCA1 mutations in breast cancer and ovarian cancer: results from three U.S. population-based case-control studies of ovarian cancer","volume":"60","author":"Whittemore","year":"1997","journal-title":"Am. J. Hum. Genet"},{"key":"10.1093\/jn\/133.11.3767S_bib16","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/00125817-200005000-00004","article-title":"Family history-taking in community family practice: implications for genetic screening","volume":"2","author":"Acheson","year":"2000","journal-title":"Genet. Med"},{"key":"10.1093\/jn\/133.11.3767S_bib17","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1200\/JCO.2002.20.2.528","article-title":"Identification and referral of families at high risk for cancer susceptibility","volume":"20","author":"Sweet","year":"2002","journal-title":"J. Clin. Oncol"},{"key":"10.1093\/jn\/133.11.3767S_bib18","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/00125817-199811000-00005","article-title":"Primary care physicians' utilization and perceptions of genetics services","volume":"1","author":"Hayflick","year":"1998","journal-title":"Genet. Med"},{"key":"10.1093\/jn\/133.11.3767S_bib19","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1093\/annonc\/mdg169","article-title":"Cancer prevalence in the UK: results from the EUROPREVAL study","volume":"14","author":"Forman","year":"2003","journal-title":"Ann. Oncol"},{"key":"10.1093\/jn\/133.11.3767S_bib20","first-page":"496","article-title":"Prevalence and contribution of BRCA1 mutations in breast cancer and ovarian cancer: results from three U.S. population-based case-control studies of ovarian cancer","volume":"60","author":"Whittemore","year":"1997","journal-title":"Am. J. Hum. Genet"},{"key":"10.1093\/jn\/133.11.3767S_bib21","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1200\/JCO.2002.05.121","article-title":"BRCAPRO validation, sensitivity of genetic testing of BRCA1\/BRCA2, and prevalence of other breast cancer susceptibility genes","volume":"20","author":"Berry","year":"2002","journal-title":"J. Clin. Oncol"},{"key":"10.1093\/jn\/133.11.3767S_bib22","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1093\/jnci\/81.24.1879","article-title":"Projecting individualized probabilities of developing breast cancer for white females who are being examined annually","volume":"81","author":"Gail","year":"1989","journal-title":"J. Natl. Cancer Inst"},{"key":"10.1093\/jn\/133.11.3767S_bib23","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1046\/j.1524-4741.2002.08005.x","article-title":"Limitations of the Gail model in the specialized breast cancer risk assessment clinic","volume":"8","author":"Euhus","year":"2002","journal-title":"Breast J"},{"key":"10.1093\/jn\/133.11.3767S_bib24","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1046\/j.1524-4741.2001.20012.x","article-title":"Understanding mathematical models for breast cancer risk assessment and counseling","volume":"7","author":"Euhus","year":"2001","journal-title":"Breast J"},{"key":"10.1093\/jn\/133.11.3767S_bib25","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1093\/aje\/154.10.916","article-title":"Family breast cancer history and mammography. Framingham Offspring Study","volume":"154","author":"Murabito","year":"2001","journal-title":"Am. J. Epidemiol"},{"key":"10.1093\/jn\/133.11.3767S_bib26","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0091-7435(01)80009-8","article-title":"Health beliefs and endoscopic screening for colorectal cancer: potential for cancer prevention","volume":"33","author":"Codori","year":"2001","journal-title":"Prev. Med"},{"key":"10.1093\/jn\/133.11.3767S_bib27","doi-asserted-by":"crossref","first-page":"59","DOI":"10.7326\/0003-4819-137-1-200207020-00017","article-title":"Chemoprevention of breast cancer: a summary of the evidence for the U.S. Preventive Services Task Force","volume":"137","author":"Kinsinger","year":"2002","journal-title":"Ann. Intern. Med"},{"key":"10.1093\/jn\/133.11.3767S_bib28","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1001\/jama.286.18.2251","article-title":"Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial","volume":"286","author":"King","year":"2001","journal-title":"J. Am. Med. Assoc"},{"key":"10.1093\/jn\/133.11.3767S_bib29","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1093\/jnci\/91.17.1475","article-title":"Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers","volume":"91","author":"Rebbeck","year":"1999","journal-title":"J. Natl. Cancer Inst"},{"key":"10.1093\/jn\/133.11.3767S_bib30","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa020119","article-title":"Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation","volume":"346","author":"Kauff","year":"2002","journal-title":"N. Engl. J. Med"},{"key":"10.1093\/jn\/133.11.3767S_bib31","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1056\/NEJMoa012158","article-title":"Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations","volume":"346","author":"Rebbeck","year":"2002","journal-title":"N. Engl. J. Med"},{"key":"10.1093\/jn\/133.11.3767S_bib32","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/S0140-6736(98)10261-1","article-title":"Screening for ovarian cancer: a pilot randomised controlled trial","volume":"353","author":"Jacobs","year":"1999","journal-title":"Lancet"},{"key":"10.1093\/jn\/133.11.3767S_bib33","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1006\/gyno.2000.5816","article-title":"The efficacy of transvaginal sonographic screening in asymptomatic women at risk for ovarian cancer","volume":"77","author":"Van","year":"2000","journal-title":"Gynecol. Oncol"},{"key":"10.1093\/jn\/133.11.3767S_bib34","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/0090-8258(91)90051-6","article-title":"Ultrasound screening for familial ovarian cancer","volume":"43","author":"Bourne","year":"1991","journal-title":"Gynecol. Oncol"},{"key":"10.1093\/jn\/133.11.3767S_bib35","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1056\/NEJM199901143400201","article-title":"Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer","volume":"140","author":"Hartmann","year":"1999","journal-title":"N. Engl. J. Med"},{"key":"10.1093\/jn\/133.11.3767S_bib36","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/S0140-6736(02)08434-9","article-title":"Outcome of conservatively managed early-onset breast cancer by BRCA1\/2 status","volume":"359","author":"Haffty","year":"2002","journal-title":"Lancet"},{"key":"10.1093\/jn\/133.11.3767S_bib37","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1136\/bmj.322.7293.1052","article-title":"The complexities of predictive genetic testing","volume":"322","author":"Evans","year":"2001","journal-title":"BMJ"},{"key":"10.1093\/jn\/133.11.3767S_bib38","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/ng0197-103","article-title":"Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene","volume":"15","author":"Gayther","year":"1997","journal-title":"Nat. Genet"},{"key":"10.1093\/jn\/133.11.3767S_bib39","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1086\/318181","article-title":"Variation in cancer risks, by mutation position, in BRCA2 mutation carriers","volume":"68","author":"Thompson","year":"2001","journal-title":"Am. J. Hum. Genet"},{"key":"10.1093\/jn\/133.11.3767S_bib40","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nrc726","article-title":"Modifiers of risk of hereditary breast and ovarian cancer","volume":"2","author":"Narod","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1093\/jn\/133.11.3767S_bib41","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1086\/318787","article-title":"Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer","volume":"68","author":"Risch","year":"2001","journal-title":"Am. J. Hum. Genet"},{"key":"10.1093\/jn\/133.11.3767S_bib42","first-page":"265","article-title":"Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium","volume":"56","author":"Easton","year":"1995","journal-title":"Am. J. Hum. Genet"},{"key":"10.1093\/jn\/133.11.3767S_bib43","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0140-6736(94)91578-4","article-title":"Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium","volume":"343","author":"Ford","year":"1994","journal-title":"Lancet"},{"key":"10.1093\/jn\/133.11.3767S_bib44","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1001\/jama.288.14.1762","article-title":"Limitations of direct-to-consumer advertising for clinical genetic testing","volume":"288","author":"Gollust","year":"2002","journal-title":"J. Am. Med. Assoc"},{"key":"10.1093\/jn\/133.11.3767S_bib45","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1136\/bmj.322.7293.1056","article-title":"Genetic risk and behavioural change","volume":"322","author":"Marteau","year":"2001","journal-title":"BMJ"},{"key":"10.1093\/jn\/133.11.3767S_bib46","unstructured":"Rose, G. A. (1992) The strategy of preventive medicine. Oxford University Press, Oxford, UK."},{"key":"10.1093\/jn\/133.11.3767S_bib47","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1002\/(SICI)1097-0142(19991201)86:11+<2564::AID-CNCR13>3.0.CO;2-P","article-title":"Genetic susceptibility for specific cancers. Medical liability of the clinician","volume":"86","author":"Severin","year":"1999","journal-title":"Cancer"},{"key":"10.1093\/jn\/133.11.3767S_bib48","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1056\/NEJM200104053441401","article-title":"Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia","volume":"344","author":"Druker","year":"2001","journal-title":"N. Engl. J. Med"},{"key":"10.1093\/jn\/133.11.3767S_bib49","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1056\/NEJMe030009","article-title":"Imatinib mesylate\u2013the new gold standard for treatment of chronic myeloid leukemia","volume":"348","author":"Peggs","year":"2003","journal-title":"N. Engl. J. Med"},{"key":"10.1093\/jn\/133.11.3767S_bib50","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1056\/NEJMoa022457","article-title":"Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia","volume":"348","author":"O'Brien","year":"2003","journal-title":"N. Engl. J. Med"},{"key":"10.1093\/jn\/133.11.3767S_bib51","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/(SICI)1096-8628(19970822)71:3<315::AID-AJMG12>3.0.CO;2-N","article-title":"Family history: a comprehensive genetic risk assessment method for the chronic conditions of adulthood","volume":"71","author":"Scheuner","year":"1997","journal-title":"Am. J. Med. Genet"},{"key":"10.1093\/jn\/133.11.3767S_bib52","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/fampra\/16.4.426","article-title":"A systematic review of the literature exploring the role of primary care in genetic services","volume":"16","author":"Emery","year":"1999","journal-title":"Fam. Pract"}],"container-title":["The Journal of Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022316623025336?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022316623025336?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/jn\/article-pdf\/133\/11\/3767S\/24018408\/3767s.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T23:17:45Z","timestamp":1686611865000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022316623025336"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,11]]},"references-count":52,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2003,11]]}},"alternative-id":["S0022316623025336"],"URL":"https:\/\/doi.org\/10.1093\/jn\/133.11.3767s","relation":{},"ISSN":["0022-3166"],"issn-type":[{"value":"0022-3166","type":"print"}],"subject":[],"published":{"date-parts":[[2003,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cancer Genetics in Primary Care","name":"articletitle","label":"Article Title"},{"value":"The Journal of Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1093\/jn\/133.11.3767S","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2003 American Society for Nutrition. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}